Advertisement
Home Blog Page 1540
Maybel Jong and Dr David Shulkin

HD Live! Takes a Look Back at Pandemic’s Progression

0

David Shulkin, M.D., and Joel Zivot, M.D., discuss handling of pandemic, overcoming vaccine hesitancy

Kids' Weight Rises When Convenience Stores Open Nearby: Study

Obesity, Eating Disorders More Common in Sexual-, Gender-Minority Youth

0

Findings suggest that disparities in weight, eating disorders observed in SGM adolescents/adults may emerge in childhood

HealthDay Reports: Troponin I Elevation Linked to Death in COVID-19 Patients

LY-CoV555 Not Efficacious for Hospitalized Patients With COVID-19

0

Enrollment stopped for futility based on no difference in pulmonary function on day 5 compared with placebo

Middle-Age Sleep Patterns Tied to Subsequent Cognitive Decline

0

Among middle-aged Hispanic adults, longer time to fall asleep tied to later global decline

Smoking Has Negative Effects for Patients With Psoriasis

Patients With Psoriasis Shoulder Substantial Psychological Burden

0

About half of patients from a university hospital dermatology department had evidence of mental health problems

Pembrolizumab Slows MSI-H-dMMR Metastatic CRC

Triple Treatment Combo Beneficial in BRAF-Mutant CRC

0

Irinotecan, cetuximab, and vemurafenib improve progression-free survival in BRAFV600E-mutated colorectal cancer

Women Have Lower Survival to Hospital Discharge After OHCA

0

Women have significantly reduced survival to hospital discharge among patients not made DNR or who do not have withdrawal of life-sustaining therapy

Esophageal Cancer on the Rise in Younger Adults

Incidence of Young-Onset Esophageal Adenocarcinoma Rising

0

Young-onset esophageal adenocarcinoma presenting at more advanced stages; proportion of advanced stage up from 1975 to 2015

Early Tracheostomy May Be Considered in Severe COVID-19

0

Findings challenge recommendations to delay or avoid tracheostomy in this patient population

SARS-CoV-2 Infection Rate Low in Patients Receiving Antitumor Therapy

0

Less than 1 percent of patients receiving antitumor treatment between Jan. 15 and May 4, 2020, developed COVID-19